Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
1 clinical trials · Condition
◉ Watch Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
| Record | Firm | Date |
|---|---|---|
| Post - Marketing Case Registration Study on the Safety and Efficacy of Adalimumab Solution for Injection in Chinese Pediatric Patients With Moderate - to - Severe Active Crohn's Disease (NCT07564505) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-05-01 |
Track Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease automatically
Every clearance here is in the API, with alerts when new ones post.